Skip to content

Introductory

B-cells can produce antibodies that are less likely to self-bind than aptamers

How We Avoid Self-Recognition with Aptamers

Antibody Binding vs. Aptamer Binding The immune system has developed very effective screening methods for eliminating antibodies that bind even weakly to self targets such as serum albumin and IgG. Aptamer selection is done outside the body, on the bench which provides many advantages but implicit… Read More »How We Avoid Self-Recognition with Aptamers

Scientist in a lab carefully distributing samples into multiple test tubes on a laboratory bench.

Announcing The Future of Aptamers: Neomers

The use of the traditional SELEX method for aptamer development has led to the identification of aptamers that bind to a wide diversity of targets. However, there has been limited success with aptamers in therapeutic and diagnostic applications.  A key advantage of aptamer development over… Read More »Announcing The Future of Aptamers: Neomers

The Aptamer Advantage: Breaking Free From Antibody Uncertainty

The Aptamer Advantage: Breaking Free from Antibody Uncertainty

In the ever-evolving field of diagnostics, precision and predictability are key to developing reliable products. However, the traditional reliance on antibodies poses significant challenges due to the inherent uncertainties in measuring their binding affinity and quantity. This creates a complex, two-variable problem that complicates product… Read More »The Aptamer Advantage: Breaking Free from Antibody Uncertainty

Advantages of Aptamers – Why You Should Know Aptamers!

In the rapidly evolving field of biotechnology, researchers constantly develop new tools and technologies to address pressing matters. One such technology that has been gaining significant attention is aptamers. These versatile, single-stranded DNA or RNA molecules have the unique ability to bind to specific targets.… Read More »Advantages of Aptamers – Why You Should Know Aptamers!

en_CAEnglish